News
6 March 2023
Dexa Group Wins the Indonesia Corporate Public Relations Award for the 5th time
Dexa Group was awarded The Best Indonesia Public Relations in the Health Sector by the Indonesia Corporate Public Relation Awards (IPRA) 2023. Dexa Group has won the IPRA Award for the fifth time since 2018. With the theme “Winning Economic Growth Through Consistent Collaboration", IPRA 2023 is being held to…
16 January 2023
BPOM and Dexa Group Collaborate to Educate the Public on Good Manufacturing Practice
Domestic pharmaceutical industry with international standard, Dexa Group participated in Expo of Food and Drug Life Cycle Product Supervision held by The Indonesian National Agency of Drug and Food Control (Badan POM). This event is an educational event from Badan POM as the regulator and the pharmaceutical and food industry…
16 December 2022
Dexa Group's CEO Named Indonesia Most Acclaimed CEO 2022
For his leadership that has allowed the company to adapt successfully, make breakthroughs, and continue to make developments to provide a positive stimulant to the economy in Indonesia, Dexa Group CEO Mr. Ferry Soetikno was awarded the Indonesia Most Acclaimed CEO 2022 in the pharmaceutical category from WartaEkonomi.co. id. Indonesia…
20 October 2022
Reinforcing Pharmaceutical Products Export Commitment to Europe, Dexa Group Signs MoU with Dutch and Polish Companies
Dexa Group, a pharmaceutical company with a high international standard in Indonesia, has reaffirmed its commitment to exporting its goods to Europe. Dexa Group inked a collaboration agreement with Allgen Pharmaceutical & Generic B.V from the Netherlands and Bioton S.A from Poland through its subsidiary Ferron Par Pharmaceuticals. Allgen Pharmaceutical…
19 October 2022
President Jokowi Visits Dexa Group Booth at Trade Expo Indonesia 2022
The President of the Republic of Indonesia, Joko Widodo (Jokowi), visited the Dexa Group booth at the 2022 Trade Expo Indonesia (TEI) at ICE BSD City, Tangerang, Mr. Dexa Group Commissioner, Mrs. Gracianti Soetikno-Pandji, welcomed the President. The President was accompanied by the Coordinating Minister for the Economy of the…
28 September 2022
Dexa Group is Committed to Improving Health Services through Renovation Assistance for Inpatient Rooms at TNI AD Hospital, dr. AK Gani Palembang
Following the 53rd anniversary, Dexa Group and the Indonesian Army Health Center officially opened the renovated inpatient room at the Tk II Hospital, dr. AK Gani, Palembang. Dexa Group's devotion to providing public health services and support for the National Health Insurance (JKN) program can be seen in the refurbishment…
12 September 2022
Synergy of Dexa Group, National Population, and Family Planning Agency, and Indonesian Midwives Association to Pursue a 14% Reduction of Stunting in 2024
According to the Indonesian Toddler Nutrition Status Survey (SSGBI), the incidence of stunting in Indonesia remains at 24.4%, much behind the 14% objective set by the 2020-2024 National Medium-Term Development Plan (RPJMN). For that purpose, Dexa Group cooperated with the National Population and Family Planning Agency (BKKBN) to host a…
1 September 2022
More Than 17 Years Trusted by Indonesian Families, STIMUNO Wins Indonesian Mom's Favorite Brand Choice Awards 2022
For more than 17 years, STIMUNO, the first phytopharmaca immunomodulator in Indonesia, had been relied on by the Indonesian Family to support the health of their immune systems. For this accomplishment, STIMUNO earned the Top 5 Indonesian Mom's Favorite Brands for Multivitamin Category in the Household & Personal Care (non-food)…
26 August 2022
Supporting Making Indonesia 4.0, Dexa Group Through Ferron Par Pharmaceuticals Accelerates The Implementation of Industry 4.0
Indonesia's Ministry of Industry accelerates seven industrial sectors, including pharmaceuticals, in implementing the Making Indonesia 4.0 roadmap to make Indonesia the top 10 big countries with the most robust economy globally by 2030. In line with this effort, as Indonesia's leading international pharmaceutical company, Dexa Group has implemented industry 4.0…
24 August 2022
Dexa Group Consistently Maintains Natural Ingredient Quality for Indonesian Phytopharmaceutical Products
Dexa Group, as a national pharmaceutical company, is committed to meeting the quality of Indonesian natural raw materials as the content of Indonesian Indigenous Modern Medicines, beginning with cultivation, harvesting, and post-harvest processes and continuing through the manufacturing process by Good Traditional Medicine Manufacturing standards (CPOTB). This is necessary to…